Boron Neutron Capture Therapy in Treating Patients With Melanoma
NCT00059800 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL
Last updated 2013-06-26
Summary
RATIONALE: Boron neutron capture therapy may selectively kill tumor cells without harming normal tissue.
PURPOSE: Phase II trial to study the effectiveness of boron neutron capture therapy in treating patients who have melanoma.
Conditions
- Melanoma (Skin)
Interventions
- RADIATION
-
boron neutron capture therapy
Sponsors & Collaborators
-
Beth Israel Deaconess Medical Center
lead OTHER
Principal Investigators
-
Paul M. Busse, MD, PhD · Beth Israel Deaconess Medical Center
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2002-05-31
- Completion
- 2004-01-31
Countries
- United States
Study Locations
More Related Trials
-
Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System
NCT00068666 ·Status: TERMINATED ·Phase: PHASE2
-
A Study to Test the Benefit of a New Anti-cancer Treatment in Patients With Unresectable Advanced Melanoma
NCT00942162 ·Status: COMPLETED ·Phase: PHASE2
-
A-dmDT390-bisFv(UCHT1) Fusion Protein With Ionizing Radiation and Pembrolizumab for the Treatment of Stage IV Melanoma
NCT02990416 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
A Phase II Trial of Neoadjuvant Treatment With PD-1 Inhibition (Nivolumab) With or Without IDO Inhibition (BMS-986205) and With or Without CTLA-4 Inhibition (Ipilimumab) in Resectable Stage III or IV Melanoma
NCT04007588 ·Status: WITHDRAWN ·Phase: PHASE2
-
MC1R-targeted Alpha-particle Monotherapy and Combination Therapy Trial With Nivolumab in Adults With Advanced Melanoma
NCT05655312 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Ibrutinib in Treating Patients With Refractory Metastatic Cutaneous Melanoma
NCT02581930 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Combination Chemotherapy, Interferon Alfa, and Interleukin-2 in Treating Patients With Metastatic Melanoma
NCT00002669 ·Status: COMPLETED ·Phase: PHASE2
-
Aldesleukin Imaging in Viewing Tumor Growth in Patients With Stage IV Melanoma Receiving Ipilimumab or Pembrolizumab Therapy
NCT01789827 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
PET and CT Scans to Evaluate Patients With Stage III or Stage IV Melanoma
NCT00004152 ·Status: COMPLETED ·Phase: PHASE2
-
A Clinical Study, to Evaluate the Safety and Tolerability of Intradermal IMM-101 in Adult Melanoma Cancer Patients
NCT01308762 ·Status: COMPLETED ·Phase: PHASE1
-
SBRT as a Vaccination for Metastatic Melanoma
NCT04042506 ·Status: WITHDRAWN ·Phase: PHASE2
-
Nuclear and Near-Infrared (NIR) Imaging in Melanoma
NCT01295931 ·Status: COMPLETED ·Phase: PHASE1
-
Safety of SBRT With Anti-PD1 and Anti-IL-8 for the Treatment of Multiple Metastases in Advanced Solid Tumors and Melanoma
NCT04572451 ·Status: RECRUITING ·Phase: PHASE1
-
Study of Core Needle Biopsy and Cryoablation of an Enlarging Tumor in Patients With Metastatic Lung Cancer and Metastatic Melanoma Receiving Post-progression Immune Checkpoint Inhibitor Therapy
NCT03290677 ·Status: COMPLETED ·Phase: NA
-
Feasibility of IV Tc-99m-tilmanocept for Imaging of M2-like TAMs in Metastatic Melanoma
NCT04663126 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
Precision Radiation of Immune Checkpoint Therapy Resistant Melanoma Metastases
NCT04793737 ·Status: RECRUITING ·Phase: NA
-
A Clinical Study of BCD-217 (Nurulimab + Prolgolimab) Followed by Anti-PD-1 Compared to Anti-PD-1 Monotherapy as First-Line Treatment in Subjects With Unresectable/Metastatic Melanoma
NCT05732805 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Antineoplaston Therapy in Treating Patients With Stage IV Melanoma
NCT00003509 ·Status: TERMINATED ·Phase: PHASE2
-
SB-715992 in Treating Patients With Metastatic or Recurrent Malignant Melanoma
NCT00095953 ·Status: COMPLETED ·Phase: PHASE2
-
SUPRAME-ACTengine® IMA203 vs. Investigator's Choice of Treatment in Previously Treated, Unresectable or Metastatic Cutaneous Melanoma
NCT06743126 ·Status: RECRUITING ·Phase: PHASE3
-
A Study of NKTR-214 Combined With Nivolumab vs Nivolumab Alone in Participants With Previously Untreated Inoperable or Metastatic Melanoma
NCT03635983 ·Status: COMPLETED ·Phase: PHASE3
-
A Phase II Trial of PD-L1 Therapy Combined With Anti-VEGF Therapy in Unresectable or Metastatic Melanoma
NCT04356729 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Bioelectric Field Imaging in Diagnosing Melanoma and Other Skin Cancers in Patients With Skin Lesions
NCT00391300 ·Status: UNKNOWN ·Phase: PHASE1
-
Interferon Alfa-2b With or Without Radiation Therapy in Treating Patients With Melanoma That Has Metastasized to Lymph Nodes in the Neck, Under the Arm, or in the Groin
NCT00003444 ·Status: COMPLETED ·Phase: PHASE3
-
Adoptive Tumor-infiltrating Lymphocyte Transfer With Nivolumab for Melanoma
NCT04165967 ·Status: COMPLETED ·Phase: PHASE1